cancer

Open Access
Usage of Complementary and Alternative Methods, Lifestyle, and Psychological Variables in Cancer Care
CATALINA HOPPE, JENS BUNTZEL, LUDWIG FISCHER VON WEIKERSTHAL, CONSTANZE JUNGHANS, BIJAN ZOMORODBAKHSCH, CHRISTOPH STOLL, FRANZ-JOPSEF PROTT, STEFAN FUXIUS, OLIVER MICKE, ACHIM RICHTER, DOREEN SALLMANN and JUTTA HUBNER

In Vivo January 2023, 37 (1) 106-114; DOI: https://doi.org/10.21873/invivo.13059
Open Access
Validation of the Rat Model of Prostate Cancer: Correlating Seminal Vesicle Lesions With Dorsolateral Prostate Lesions
ELISABETE NASCIMENTO-GONÇALVES, FERNANDA SEIXAS, BRUNO MIGUEL MAIO OLIVEIRA, JOÃO EDUARDO TEIGA-TEIXEIRA, ANA I. FAUSTINO-ROCHA, BRUNO COLAÇO, RITA FERREIRA and PAULA A. OLIVEIRA

In Vivo November 2022, 36 (6) 2662-2668; DOI: https://doi.org/10.21873/invivo.13001
Open Access
Effect of Propofol and Etomidate on the Proliferation, Cell-cycle Distribution, Apoptosis and Necrosis of Pancreatic Tumour Cells
MANUELA MALSY, BERNHARD GRAF, VERONIKA HOFER, DIANE BITZINGER and ANIKA BUNDSCHERER

In Vivo November 2022, 36 (6) 2722-2729; DOI: https://doi.org/10.21873/invivo.13008
Open Access
Prognostic Factors for Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery
NAO KITASAKI, YOICHI HAMAI, MANABU EMI, TOMOAKI KUROKAWA, TORU YOSHIKAWA, RYOSUKE HIROHATA, MANATO OHSAWA and MORIHITO OKADA

In Vivo November 2022, 36 (6) 2852-2860; DOI: https://doi.org/10.21873/invivo.13025
Open Access
Survival Analysis Using the Covid-death Mean-imputation (CoDMI) Algorithm: A First Clinical Application in Radiation Oncology
FRANCESCA DE FELICE, LUCA MAZZONI, DANIELA MUSIO, VINCENZO TOMBOLINI and FRANCO MORICONI

In Vivo November 2022, 36 (6) 2986-2992; DOI: https://doi.org/10.21873/invivo.13043
Open Access
Cancer Patient Motives and Expectations on Non-medical Practitioners
CHRISTIAN KEINKI, EMADALDIN AHMADI, KARIN KASTRATI, BIJAN ZOMORODBAKHSCH, JUTTA HÜBNER and on behalf of the Working Group Prevention and Integrative Oncology of the German Cancer Society (PRIO)

In Vivo September 2022, 36 (5) 2505-2513; DOI: https://doi.org/10.21873/invivo.12986
You have access
Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What About Pancreatic Cancer?
NIKOLAOS GARMPIS, CHRISTOS DAMASKOS, DIMITRIOS DIMITROULIS, ANNA GARMPI, EVANGELOS DIAMANTIS, PANAGIOTIS SARANTIS, VASILIKI E. GEORGAKOPOULOU, ALEXANDROS PATSOURAS, DIONYSIOS PREVEZANOS, ATHANASIOS SYLLAIOS, GEORGIOS KYRIAKOS, EVANGELOS KOUSTAS, MARKOS DESPOTIDIS, CHRISTOS VALLILAS, PETROS PAPALEXIS, EFSTATHIOS A. ANTONIOU, KONSTANTINOS KONTZOGLOU and GREGORY KOURAKLIS

In Vivo March 2022, 36 (2) 543-555; DOI: https://doi.org/10.21873/invivo.12736
You have access
The Effects of Analgesics on the Migration of Pancreatic Cancer Cells
MANUELA MALSY, CHRISTINA HACKL, BERNHARD GRAF, DIANE BITZINGER and ANIKA BUNDSCHERER

In Vivo March 2022, 36 (2) 576-581; DOI: https://doi.org/10.21873/invivo.12740
You have access
Plasma Concentration of the Lipid Peroxidation (LP) Biomarker 4-Ηydroxynonenal (4-HNE) in Benign and Cancer Patients
MAARET ESKELINEN, IINA SAIMANEN, RIIKA KOSKELA, ANU HOLOPAINEN, TUOMAS SELANDER and MATTI ESKELINEN

In Vivo March 2022, 36 (2) 773-779; DOI: https://doi.org/10.21873/invivo.12764
You have access
Supportive Oligonucleotide Therapy (SOT) as an Alternative Treatment Option in Cancer: A Preliminary Study
IOANNIS PAPASOTIRIOU, GEORGIOS BEIS, AGGELOS C. ILIOPOULOS and PANAGIOTIS APOSTOLOU

In Vivo March 2022, 36 (2) 898-906; DOI: https://doi.org/10.21873/invivo.12779

Main menu

User menu

Search

cancer

Pages